1 – 19 of 19
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Radiolabeled antibodies in prostate cancer: A case study showing the effect of host immunity on antibody bio-distribution.
(
- Contribution to journal › Article
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
- 2014
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes.
(
- Contribution to journal › Article
-
Mark
Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
(
- Contribution to journal › Article
- 2012
-
Mark
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
(
- Contribution to journal › Article
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
- 2011
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
(
- Contribution to journal › Article
-
Mark
A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
(
- Contribution to journal › Article
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article
-
Mark
High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression.
(
- Contribution to journal › Article
- 2010
-
Mark
miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
Male infertility and prostate cancer risk: a nested case-control study.
(
- Contribution to journal › Article
-
Mark
PCA3 as a diagnostic marker for prostate cancer: A validation study on a Swedish patient population.
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer : Case-control study
(
- Contribution to journal › Article
- 2009
-
Mark
Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
(
- Contribution to journal › Article